These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8975939)

  • 1. Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC).
    Kohno H; Nagasue N; Hayashi T; Yamanoi A; Uchida M; Ono T; Yukaya H; Kimura N; Nakamura T
    Hepatogastroenterology; 1996; 43(12):1405-9. PubMed ID: 8975939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
    Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
    Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
    Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K
    Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
    Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
    Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic chemolipiodolization for postoperative hepatoma patients.
    Shimoda M; Bando T; Nagata T; Shirosaki I; Sakamoto T; Tsukada K
    Hepatogastroenterology; 2001; 48(38):493-7. PubMed ID: 11379340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma.
    Boucher E; Corbinais S; Rolland Y; Bourguet P; Guyader D; Boudjema K; Meunier B; Raoul JL
    Hepatology; 2003 Nov; 38(5):1237-41. PubMed ID: 14578862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Miyazaki I
    Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma.
    Nakashima K; Kitano S; Kim YI; Aramaki M; Kawano K
    Hepatogastroenterology; 1996; 43(12):1410-4. PubMed ID: 8975940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
    Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
    Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].
    Mo QG; Liang AM; Yang NW; Zhao YN; Yuan WP
    Ai Zheng; 2003 Feb; 22(2):189-91. PubMed ID: 12600298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].
    Lü MD; Kuang M; Liang LJ; Xie XY; Peng BG; Liu GJ; Li DM; Lai JM; Li SQ
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):801-5. PubMed ID: 16681964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment and adjuvant chemotherapy in hepatocellular carcinoma patients with advanced vascular involvement.
    Nanashima A; Sumida Y; Abo T; Nagasaki T; Ohba K; Kinoshita H; Tobinaga S; Kenji T; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2008; 55(82-83):627-32. PubMed ID: 18613421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.